Scholars Central

OpinionPublished 30 Nov 2022

Molecular histology of lung cancer and progress in lung cancer treatments.

Authors: Jonas Muller

Journal of Medical Oncology and Therapeutics

Volume 7 · Issue 6 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Lung cancer in the lungs endurance has just hardly worked on throughout recent many years, yet the accessibility of screening and early identification by low-portion PC tomography and advances in designated medicines and immunotherapy will probably diminish death rates and further develop patient endurance results sooner rather than later. Lung cancer in the lungs is the main source of disease mortality.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Medical Oncology and Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Medical Oncology and Therapeutics
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Jonas Muller”